Kwihlabathi elikhuphisana kakhulu lophuhliso lwamachiza, ukufumana iyeza elitsha kwimarike ngokukhawuleza kunokuba nefuthe elikhulu kwishishini. Mhlawumbi akukho mzekelo wamva nje ongcono kunoNovo Nordisk, ovelise phantse i-100 yeebhiliyoni zeedola ekuthengisweni kweziyobisi zokunciphisa umzimba i-Ozempic kunye ne-Wegovy ngelixa uzama ukuthintela ukhuphiswano oluvela ku-Eli Lilly.
Ngoku, uNovo Nordisk uthi usebenzisa ii-arhente ze-AI ukucutha ngeeveki okanye iinyanga ixesha elithathayo ukuqalisa iimvavanyo ezintsha zeklinikhi kunye nokuzigqiba. Izixhobo ezitsha kulindeleke ukuba zongeze amashumi okanye amakhulu ezigidi zeedola kwingeniso eyongezelelweyo ngelixa inceda inkampani iqeshe abasebenzi abambalwa, ngokutsho kweGosa eliyiNtloko leDijithali uStephanie Bova.
